EssilorLuxottica (OTCMKTS:ESLOY) Hits New 1-Year Low – What’s Next?

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY)’s stock price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $118.51 and last traded at $118.8610, with a volume of 24591 shares trading hands. The stock had previously closed at $123.37.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. HSBC raised EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Wednesday, January 14th. Citigroup reaffirmed a “buy” rating on shares of EssilorLuxottica in a research note on Thursday, December 11th. The Goldman Sachs Group reissued a “buy” rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Kepler Capital Markets upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Thursday, January 15th. Finally, UBS Group raised EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 27th. Two research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy”.

EssilorLuxottica Trading Down 0.2%

The firm has a 50 day moving average of $148.91 and a 200-day moving average of $161.44. The company has a quick ratio of 0.67, a current ratio of 0.97 and a debt-to-equity ratio of 0.18.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.